Study of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin and Irinotecan in Subjects With Metastatic Pancreatic Cancer

NCT02324543 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Pancreatic Adenocarcinoma

Interventions

DRUG: Gemcitabine
DRUG: Taxotere
DRUG: Xeloda
DRUG: Cisplatin
DRUG: Irinotecan

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]